Status:

UNKNOWN

Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast Cancer

Lead Sponsor:

Heinrich-Heine University, Duesseldorf

Conditions:

Breast Cancer

Eligibility:

FEMALE

18-65 years

Phase:

NA

Brief Summary

RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination ch...

Detailed Description

OBJECTIVES: Primary * Compare the disease-free survival rate in women with stage III breast cancer treated with adjuvant chemotherapy with vs without darbepoetin alfa. Secondary * Compare local re...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Histologically confirmed breast cancer
  • Stage III disease (pT1, N2-3, M0)
  • No metastatic disease by thoracic x-ray, full-body bone scan, and liver sonography
  • No inflammatory disease or Paget's disease
  • Disease completely resected (R0) and ≥ 10 axillary lymph nodes removed
  • Underwent surgery approximately 42 days ago
  • At least 9 positive lymph nodes
  • No prior sequential mastectomy
  • Hormone receptor status not specified
  • PATIENT CHARACTERISTICS:
  • Female
  • Menopausal status not specified
  • ECOG performance status 0-1
  • WBC ≥ 3,500/mm\^3
  • Creatinine ≤ 1.4 mg/dL
  • Platelet count ≥ 100,000/mm\^3
  • Bilirubin ≤ 2.0 mg/dL
  • No pre-existing symptomatic peripheral neuropathy
  • Not pregnant or nursing
  • No hypersensitivity to darbepoetin alfa, epoetin alfa, or any of their components
  • No other malignancy except curatively treated basal cell skin cancer or carcinoma in situ of the cervix
  • PRIOR CONCURRENT THERAPY:
  • See Disease Characteristics
  • No participation in another clinical study
  • No prior therapies that would preclude study participation

Exclusion

    Key Trial Info

    Start Date :

    January 1 2004

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    Estimated Enrollment :

    1234 Patients enrolled

    Trial Details

    Trial ID

    NCT00309920

    Start Date

    January 1 2004

    Last Update

    February 9 2009

    Active Locations (47)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 12 (47 locations)

    1

    Kreiskrankenhaus Aurich

    Aurich, Germany, D-26603

    2

    Maria-Hilf-Krankenhaus

    Bergheim, Germany, D-50126

    3

    Evangelisches Krankenhaus - Bergisch Gladbach

    Bergisch, Germany, D-51465

    4

    Johanniter-Krankenhaus Bonn

    Bonn, Germany, D-53113

    Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast Cancer | DecenTrialz